Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Jagielski, Tomasz ^a   Ignatowska, Helena ^a   Bakuła, Zofia ^a   Dziewit, Łukasz ^a   Napiórkowska, Agnieszka ^b   Augustynowicz Kopeć, Ewa ^b   Zwolska, Zofia ^b   Bielecki, Jacek ^a  

^a UNIVERSITY OF WARSAW   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; MOLECULAR MARKER; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT; METHYLTRANSFERASE; RIBOSOMAL PROTEIN S12; RIBOSOME PROTEIN; RNA 16S;

AMERICAN MEDITERRANEAN; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CELL LINEAGE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG SCREENING; EPSILOMETER TEST; ETHNIC GROUP; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GIDB GENE; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLAND; RPSL GENE; RRS GENE; SPECTRUM; TUBERCULOSIS; GENETICS; ISOLATION AND PURIFICATION; MUTATION;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; HUMANS; METHYLTRANSFERASES; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHYLOGENY; POLAND; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL, 16S; STREPTOMYCIN;

EID: 84903289144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0100078     Document Type: Article

References (40)

1. th ed. World Health Organization, Geneva, Switzerland. WHO/HTM/TB/2009.420.
2. Musser J (1995) Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 8: 496-514.
3. Cooksey RC, Morlock GP, McQueen A, Glickman SE, Crawdord JT (1996) Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother 40: 1186-1188. (Pubitemid 26136032)
4. Meier A, Sander P, Schaper KJ, Scholz M, Böttger EC (1996) Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin- resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 40: 2452-2454. (Pubitemid 26367624)
5. Abbadi SH, Sameaa GA, Morlock G, Cooksey RC (2009) Molecular identification of mutations associated with anti-tuberculosis drug resistance among strains of Mycobacterium tuberculosis. Int J Infect Dis 13: 673-678.
6. Tudó G, Rey E, Borrell S, Alcaide F, Codina G, et al. (2010) Characterization of mutations in streptomycin-resistant Mycobacterium tuberculosis clinical isolates in the area of Barcelona. J Antimicrob Chemother 65: 2341-2346.
7. Nhu NT, Lan NT, Phuong NT, Chau Nv, Farrar J, et al. (2012) Association of streptomycin resistance mutations with level of drug resistance and Mycobacterium tuberculosis genotypes. Int J Tuberc Lung Dis 16: 527-531.
8. Okamoto S, Tamaru A, Nakajima C, Nishimura K, Tanaka Y, et al. (2007) Loss of a conserved 7-methylguanosine modification in 16S rRNA confers low-level streptomycin resistance in bacteria. Mol Microbiol 63: 1096-1106. (Pubitemid 46188264)
9. Spies FS, da Silva PE, Ribeiro MO, Rossetti ML, Zaha A (2008) Identification of mutations related to streptomycin resistance in clinical isolates of Mycobacterium tuberculosis and possible involvement of efflux mechanism. Antimicrob Agents Chemother 52: 2947-2949.
10. Wong SY, Lee JS, Kwak HK, Via LE, Boshoff HIL, et al. (2011) Mutations in gidB confer low-level streptomycin resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 55: 2515-2522.
11. Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M (2003) Drug-resistant tuberculosis in Poland in 2000: second national survey and comparison with the 1997 survey. Int J Tuberc Lung Dis 7: 645-651. (Pubitemid 36806859)
12. World Health Organization (2003) Guidelines for surveillance of drug resistance in tuberculosis. World Health Organization, Geneva, Switzerland. WHO/TB/2003.320.
13. Joloba ML, Bajaksouzian S, Jacobs MR (2000) Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 38: 3834-3836.
14. Hazbón MH, del Socorro Orozco M, Labrada LA, Tovar R, Kristen AW, et al. (2000) Evaluation of Etest for susceptibility testing of multidrug-resistant isolates of Mycobacterium tuberculosis. J Clin Microbiol 38: 4599-4603. (Pubitemid 32244555)
15. van Embden JDA, Cave MD, Crawford JT, Dale JW, Eisenach KD, et al. (1993) Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 31: 406-409. (Pubitemid 23028649)
16. Jagielski T, Augustynowicz-Kopec E, Zozio T, Rastogi N, Zwolska Z (2010) Spoligotype-based comparative population structure analysis of multidrugresistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland. J Clin Microbiol 48: 3899-3909.
17. Vitol I, Driscoll J, Kreiswirth B, Kurepina N, Bennett KP. (2006) Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infect Genet Evol 6: 491-504. (Pubitemid 44542627)
18. Jnawali HN, Yoo H, Ryoo S, Lee KJ, Kim BJ, et al. (2013) Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea. World J Microbiol Biotechnol 29: 975-982.
19. Ballif M, Harino P, Ley S, Coscolla M, Niemann S, et al. (2012) Drug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea. BMC Microbiol 12: 191.
20. Jnawali HN, Hwang SC, Park YK, Kim H, Lee YS, et al. (2013) Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagn Microbiol Infect Dis 76: 187-196.
21. Brzostek A, Sajduda A, Sliwiński T, Augustynowicz-Kopeć E, Jaworski A, et al. (2004) Molecular characterization of streptomycin-resistant Mycobacterium tuberculosis strains isolated in Poland. Int J Tuberc Lung Dis 8: 1032-1035. (Pubitemid 39024910)
22. Shi R, Zhang J, Li C, Kazumi Y, Sugawara I (2007) Detection of streptomycin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by denaturing HPLC analysis and DNA sequencing. Microbes Infect 9: 1538-1544. (Pubitemid 350217078)
23. Katsukawa C, Tamaru A, Miyata Y, Abe C, Makino M, et al. (1997) Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. J Appl Microbiol 83: 634-640. (Pubitemid 27498346)
24. Dobner P, Bretzel G, Rüsch-Gerdes S, Feldmann K, Rifai M, et al. (1997) Geographic variation of the predictive values of genomic mutations associated with streptomycin resistance in Mycobacterium tuberculosis. Mol Cell Probes. 11:123-126. (Pubitemid 27267718)
25. Sreevatsan S, Pan X, Stockbauer KE, Williams DL, Kreiswirth BN, et al. (1996) Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob Agents Chemother 40: 1024-1026. (Pubitemid 26115243)
26. Cuevas-Córdoba B, Cuellar-Sánchez A, Pasissi-Crivelli A, Santana-Álvarez CA, Hernández-Illezcas J, et al. (2013) rrs and rpsL mutations in streptomycinresistant isolates of Mycobacterium tuberculosis from Mexico. J Microbiol Immunol Infect 46: 30-34.
27. Feuerriegel S, Oberhauser B, George AG, Dafae F, Richter E, et al. (2012) Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence setting. BMC Microbiol. 12: 90.
28. Siddiqi N, Shamim M, Hussain S, Choudhary RK, Ahmed N, et al. (2002) Molecular characterization of multidrug-resistant isolates of Mycobacterium tuberculosis from patients in North India. Antimicrob Agents Chemother 46:443-450. (Pubitemid 34087194)
29. Spies FS, Ribeiro AW, Ramos DF, Ribeiro MO, Martin A, et al. (2011) Streptomycin resistance and lineage-specific polymorphisms in Mycobacterium tuberculosis gidB gene. J Clin Microbiol 49: 2625-2630.
30. Yadav R, Sethi S, Dhatwalia SK, Gupta D, Mewara A, et al. (2013) Molecular characterization of drug resistance in Mycobacterium tuberculosis isolates from North India. Int J Tuberc Lung Dis 17: 251-257.
31. Sun YJ, Luo JT, Wong SY, Lee AS (2010) Analysis of rpsL and rrs mutations in Beijing and non-Beijing streptomycin-resistant Mycobacterium tuberculosis isolates from Singapore. Clin Microbiol Infect 16: 287-289.
32. Ramaswamy SV, Dou SJ, Rendon A, Yang Z, Cave MD, et al. (2004) Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 53: 107-113. (Pubitemid 38223688)
33. Perdigão J, Macedo R, João I, Fernandes E, Brum L, et al. (2008) Multidrugresistant tuberculosis in Lisbon, Portugal: a molecular epidemiological perspective. Microb Drug Resist 14: 133-143.
34. Spies FS, von Groll A, Ribeiro AW, Ramos DF, Ribeiro MO, et al. (2013) Biological cost in Mycobacterium tuberculosis with mutations in the rpsL, rrs, rpoB, and katG genes. Tuberculosis 93: 150-154.
35. Van Rie A, Warren R, Mshanga I, Jordaan AM, van der Spuy GD, et al. (2001) Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 39: 636-641. (Pubitemid 32150832)
36. Homolka S, Projahn M, Feuerriegel S, Ubben T, Diel R, et al. (2012) High resolution discrimination of clinical Mycobacterium tuberculosis complex strains based on single nucleotide polymorphisms. PLoS One 7: e39855.
37. Abadia E, Zhang J, dos Vultos T, Ritacco V, Kremer K, et al. (2010) Resolving lineage assignation on Mycobacterium tuberculosis clinical isolates classified by spoligotyping with a new high-throughput 3R SNPs based method. Infect Genet Evol 10: 1066-1074.
38. Homolka S, Köser C, Archer J, Rüsch-Gerdes S, Niemann S. (2009) Singlenucleotide polymorphisms in Rv2629 are specific for Mycobacterium tuberculosis genotypes Beijing and Ghana but not associated with rifampin resistance. J Clin Microbiol 47: 223-226.
39. Ignatova A, Dubiley S, Stepanshina V, Shemyakin I (2006) Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Med Microbiol 55: 1413-1418. (Pubitemid 44651669)
40. Pardini M, Niemann S, Varaine F, Iona E, Meacci F, et al. (2009) Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a highprevalence area in Eastern Europe. Tuberculosis 89: 317-324.